Reuters -- Bristol-Myers Squibb Co (BMY.N) set a baseline for profits in 2013 as it provided investors their first glimpse of life after Plavix, the world's second-bestselling drug.
Reuters -- Bristol-Myers Squibb Co (BMY.N) set a baseline for profits in 2013 as it provided investors their first glimpse of life after Plavix, the world's second-bestselling drug.